Macrophages and atherosclerotic plaque stability

Current Opinion in Lipidology

Volumn 7, Issue 5, 1996, Pages 330-335

  Libby, Peter ^a   Geng, Yong Jian ^a   Aikawa, Masanori ^a   Schoenbeck, Uwe ^a   Mach, François ^a   Clinton, Steven K ^a   Sukhova, Galina K ^a   Lee, Richard T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN E; COLLAGEN; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROCOAGULANT; SIMVASTATIN; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTERY INTIMA; ARTERY WALL; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CELL DEATH; CELL MIGRATION; CLINICAL TRIAL; EXTRACELLULAR MATRIX; FOAM CELL; HUMAN; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SHORT SURVEY; THROMBOGENESIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0029807088     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199610000-00012     Document Type: Short Survey

References (45)

1. Falk E, Shah P, Fuster V: Coronary plaque disruption. Circulation 1995, 92:657-671. An authoritative review of the clinical and biological aspects of atheroma instability by a leading group of investigators.
2. Davies M: The Paul Dudly White lecture. Circulation 1996 (In press).
3. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J: Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content Br Heart J 1993, 69:377-381
4. Loree HM, Kamm RD, Stringfellow RG, Lee RT: Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992, 71:850-858.
5. van der Wal AC, Becker AE, van der Loos CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
6. Farb A, Burke A, Tang A, Liang Y, Mannan P, Smialek J, Virmani J: Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996, 93:1354-1363. A recent post-mortem series highlighting the importance of superficial erosion as well as frank plaque rupture as a pathological substrate for acute myocardial infarction.
7. Libby P, Clinton SK: The role of macrophages in atherogenesis. Curr Opin Lipidol 1993, 4:355-363.
8. Printseva O, Peclo MM, Gown AM: Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol 1992, 140:889-896.
9. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992, 140:665-673.
10. O'Brien K, Allen M, McDonald T, Chait A, Harlan J, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin C et al: Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993, 92:945-951.
11. Bevilacqua MP, Nelson RM, Mannori G, Cecconi O: Endothelial-leukocyte adhesion molecules in human disease [Review]. Ann Rev Med 1994, 45:361-378.
12. Frenette P, Wagner D: Adhesion molecules. N Engl J Med 1996, 334:1526-1529. A current status report emphasizing endothelial-leukocyte adhesion biology.
13. Nelken N, Coughlin S, Gordon D, Wilcox J: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991, 88: 1121-1127.
14. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M: Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 1990, 343:531-535
15. Endemann G, Stanton LW, Madden KS, Bryant CM, White TR, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993, 268:11811-11816.
16. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D: The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical top macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 1995, 92:9580-9584. An example of the recent advances in understanding the molecular mediators of macrophage lipid loading.
17. Krieger M, Acton S, Ashkenas J, Pearson A, Penman M, Resnick D: Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem 1993, 268:4569-4572.
18. Basu SK, Brown MS, Ho YK, Havel RJ, Goldstein JL: Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Natl Acad Sci USA 1981, 78:7545-7549.
19. Gordon D, Reidy MA, Benditt EP, Schwartz SM: Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990, 87:4600-4604.
20. Rosenfeld ME, Ross R: Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1990, 10:680-687.
21. Libby P: Vascular cells produce and respond to cytokines. In Immune functions of the vessel wall. Edited by Hansson G, Libby P. New York: Harwood Academic Publishers; 1996: 45-64.
22. Rosenfeld M, Ylä-Herttuala S, Lipton B, Ord V, Witztum J, Steinberg D: Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 1992, 140: 291-300.
23. Clinton S, Underwood R, Sherman M, Kufe D, Libby P: Macrophage-colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992, 140:301-316.
24. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M: Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 1995, 92: 8264-8268. An important illustration of the use of a compound mutant mouse to delineate the role of a specific cytokine in an atherosclerosis model.
25. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
26. Majino G, Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995, 146:3-15. A cogent, readable, and historically grounded critical assessment of the mechanisms of cell death placed in a broad pathological context.
27. •]
28. •]
29. Geng Y-J, Libby P: Evidence for apoptosis in advanced human atheroma. Co-localization with interleukin-1β-converting enzyme. Am J Pathol 1995, 147:251-266 Three recent reports furnishing evidence for cell death in atherosclerosis, the latter paper documenting macrophage cell death in human atheroma and discussing the potential role of apoptosis in plaque destabilization.
30. Davies MJ, Thomas AC: Plaque fissuring - the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985, 53:363-373.
31. Falk E: Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983, 50:127-134.
32. Libby P: The molecular bases of the acute coronary syndromes. Circulation 1995, 91:2844-2850. An attempt to link the clinical aspects of unstable coronary syndromes and the benefits of lipid lowering with contemporary arterial wall biology.
33. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S: Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991, 88:8154-8158.
34. Galis Z, Sukhova G, Lark M, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94: 2493-2503.
35. Galis Z, Sukhova G, Libby P: Microscopic localization of active proteases by in situ zymography. Detection of matrix metalloproteinase activity in vascular tissue. FASEB J 1995, 9:974-980.
36. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G Fallon JT, Regnstrom J, Fuster V: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995, 92:1565-1569.
37. Sukhova G, Simon D, Chapman H, Libby P: Cytokines regulate the expression by vascular smooth muscle cells of cathepsin S, an elastase found in human atheroma [Abstract]. J Invest Med 1995, 43:311A.
38. Galis Z, Sukhova G, Kranzhöfer R, Clark S, Libby P: Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995, 92:402-406. A demonstration of the autonomous expression of collagenolytic enzymes by lipid-laden macrophages isolated from atheroma experimentally induced by hypercholesterolemia in rabbits.
39. Lee E, Grodzinsky A, Libby P, Clinton S, Lark M, Lee R: Human vascular smooth muscle cell-moncyte interactions and metalloproteinase secretion in culture. Arterioscler Thromb Vasc Biol 1996, 15:2284-2289.
40. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989, 86:2839-2843.
41. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT: Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994, 90:775-778.
42. Blankenhorn DH, Hodis HN: Arterial imaging and atherosclerosis reversal. Arterioscler Thromb 1994, 14:177-192.
43. Brown BG, Zhao XQ, Sacco DE, Albers JJ: Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease [Review]. Circulation 1993, 87:1781-1791.
44. Group SSSS: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandanavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383-1389.
45. Shepperd J, Cobbe S, Ford I, Isles C, Lorimer A, Macfarlane P, McKillop J, Packard C: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995, 333:1301-1307. A recently published clinical trial demonstrating a reduction in clinical events and total mortality by a lipid-lowering intervention in hypercholesterolemic men without evidence of a prior myocardial infarction.